Storyline
Employer GLP-1 weight-loss drug coverage cuts 2026-2027
One page that accretes the verified record as the story develops. Every fact keeps its date and its sources.
1 DAYS
26 FACTS
1 EVENTS
1 SOURCES
FIRST ENTRY OCT 27
OCT 27 · Day 1
Employer plans dropping GLP-1 drug coverage; 2027 weight-loss options
Novo Nordisk says current promotional pricing for Wegovy may be modified or canceled.
The annual employee contribution limit for an FSA is $3,400 in 2026.
Data from Omada Health show that 63% of members evaluated at 12 months after stopping a GLP-1 maintained or continued to lose weight.